| DB ID | MyCo_3713 |
| Title | Urine Galactomannan-to-Creatinine Ratio for Detection of Invasive Aspergillosis in Patients with Hematological Malignancies |
| Year | 2015 |
| PMID | 26699701 |
| Fungal Diseases involved | Invasive aspergillosis |
| Disease | Aspergillosis (Aspergillus Infection) |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | spp. |
| Organism | Aspergillus spp. |
| Ethical Statement | This study has been registered at ClinicalTrials.gov under registration no. NCT01576653. |
| Site of Infection | Unspecified |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Urine |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | GM |
| Biomarker Full Name | Galactomannan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Austria |
| Cohort | Here evaluated a total of 632 serial urine samples from 71 patients with underlying hematological malignancies. |
| Cohort No. | 71 |
| Age Group | 46-62 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Sub Technique | Lateral flow |
| Technique | Immunoassay |
| Analysis Method | GM Assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | GM Assay |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
